These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 28662292

  • 1. Benign and malignant tumors in the UK myotonic dystrophy patient registry.
    Alsaggaf R, Wang Y, Marini-Bettolo C, Wood L, Nikolenko N, Lochmüller H, Greene MH, Gadalla SM.
    Muscle Nerve; 2018 Feb; 57(2):316-320. PubMed ID: 28662292
    [Abstract] [Full Text] [Related]

  • 2. Pigmentation phenotype, photosensitivity and skin neoplasms in patients with myotonic dystrophy.
    Gadalla SM, Hilbert JE, Martens WB, Givens S, Moxley RT, Greene MH.
    Eur J Neurol; 2017 May; 24(5):713-718. PubMed ID: 28317292
    [Abstract] [Full Text] [Related]

  • 3. Correlates of tumor development in patients with myotonic dystrophy.
    Das M, Moxley RT, Hilbert JE, Martens WB, Letren L, Greene MH, Gadalla SM.
    J Neurol; 2012 Oct; 259(10):2161-6. PubMed ID: 22619053
    [Abstract] [Full Text] [Related]

  • 4. Increased risk of tumor in DM1 is not related to exposure to common lifestyle risk factors.
    Bianchi ML, Leoncini E, Masciullo M, Modoni A, Gadalla SM, Massa R, Rastelli E, Terracciano C, Antonini G, Bucci E, Petrucci A, Costanzi S, Santoro M, Boccia S, Silvestri G.
    J Neurol; 2016 Mar; 263(3):492-8. PubMed ID: 26739382
    [Abstract] [Full Text] [Related]

  • 5. Cancer Risk in Patients With Muscular Dystrophy and Myotonic Dystrophy: A Register-Based Cohort Study.
    Maya-González C, Tettamanti G, Taylan F, Skarin Nordenvall A, Sejersen T, Nordgren A.
    Neurology; 2024 Oct 22; 103(8):e209883. PubMed ID: 39298705
    [Abstract] [Full Text] [Related]

  • 6. Hypothesis: neoplasms in myotonic dystrophy.
    Mueller CM, Hilbert JE, Martens W, Thornton CA, Moxley RT, Greene MH.
    Cancer Causes Control; 2009 Dec 22; 20(10):2009-20. PubMed ID: 19642006
    [Abstract] [Full Text] [Related]

  • 7. Survival patterns and cancer determinants in families with myotonic dystrophy type 1.
    Best AF, Hilbert JE, Wood L, Martens WB, Nikolenko N, Marini-Bettolo C, Lochmüller H, Rosenberg PS, Moxley RT, Greene MH, Gadalla SM.
    Eur J Neurol; 2019 Jan 22; 26(1):58-65. PubMed ID: 30051542
    [Abstract] [Full Text] [Related]

  • 8. Reproductive Cancer Risk Factors in Women With Myotonic Dystrophy (DM): Survey Data From the US and UK DM Registries.
    Higgs C, Hilbert JE, Wood L, Martens WB, Marini-Bettolo C, Nikolenko N, Alsaggaf R, Lochmüller H, Moxley RT, Greene MH, Wang Y, Gadalla SM.
    Front Neurol; 2019 Jan 22; 10():1071. PubMed ID: 31681146
    [Abstract] [Full Text] [Related]

  • 9. Brain tumors in patients with myotonic dystrophy: a population-based study.
    Gadalla SM, Pfeiffer RM, Kristinsson SY, Björkholm M, Landgren O, Greene MH.
    Eur J Neurol; 2016 Mar 22; 23(3):542-7. PubMed ID: 26508558
    [Abstract] [Full Text] [Related]

  • 10. Benign tumors in myotonic dystrophy type I target disease-related cancer sites.
    Alsaggaf R, St George DMM, Zhan M, Pfeiffer RM, Wang Y, Anderson LA, Liu Z, Koshiol J, Bauer AJ, Wagner KR, Greene MH, Amr S, Gadalla SM.
    Ann Clin Transl Neurol; 2019 Aug 22; 6(8):1510-1518. PubMed ID: 31402615
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Quantifying cancer absolute risk and cancer mortality in the presence of competing events after a myotonic dystrophy diagnosis.
    Gadalla SM, Pfeiffer RM, Kristinsson SY, Björkholm M, Hilbert JE, Moxley RT, Landgren O, Greene MH.
    PLoS One; 2013 Aug 22; 8(11):e79851. PubMed ID: 24236163
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A population-based survey of risk for cancer in individuals diagnosed with myotonic dystrophy.
    Abbott D, Johnson NE, Cannon-Albright LA.
    Muscle Nerve; 2016 Oct 22; 54(4):783-5. PubMed ID: 27064430
    [Abstract] [Full Text] [Related]

  • 15. The UK Myotonic Dystrophy Patient Registry: facilitating and accelerating clinical research.
    Wood L, Cordts I, Atalaia A, Marini-Bettolo C, Maddison P, Phillips M, Roberts M, Rogers M, Hammans S, Straub V, Petty R, Orrell R, Monckton DG, Nikolenko N, Jimenez-Moreno AC, Thompson R, Hilton-Jones D, Turner C, Lochmüller H.
    J Neurol; 2017 May 22; 264(5):979-988. PubMed ID: 28397002
    [Abstract] [Full Text] [Related]

  • 16. Cancer phenotype in myotonic dystrophy patients: Results from a meta-analysis.
    Emparanza JI, López de Munain A, Greene MH, Matheu A, Fernández-Torrón R, Gadalla SM.
    Muscle Nerve; 2018 Oct 22; 58(4):517-522. PubMed ID: 30028904
    [Abstract] [Full Text] [Related]

  • 17. Cardiac involvement in myotonic dystrophy: a nationwide cohort study.
    Lund M, Diaz LJ, Ranthe MF, Petri H, Duno M, Juncker I, Eiberg H, Vissing J, Bundgaard H, Wohlfahrt J, Melbye M.
    Eur Heart J; 2014 Aug 21; 35(32):2158-64. PubMed ID: 24742887
    [Abstract] [Full Text] [Related]

  • 18. Risk of cancer in relatives of patients with myotonic dystrophy: a population-based cohort study.
    Lund M, Diaz LJ, Gørtz S, Feenstra B, Duno M, Juncker I, Eiberg H, Vissing J, Wohlfahrt J, Melbye M.
    Eur J Neurol; 2014 Sep 21; 21(9):1192-7. PubMed ID: 24838088
    [Abstract] [Full Text] [Related]

  • 19. [Prevalence of myotonic dystrophy in Iceland].
    Leifsdóttir G, Benedikz JE, Jóhannesson G, Jónsson JJ, Sveinbjörnsdóttir S.
    Laeknabladid; 2005 Nov 21; 91(11):829-34. PubMed ID: 16264243
    [Abstract] [Full Text] [Related]

  • 20. [Increasing risk of tumors in myotonic dystrophy type 1].
    Mohamed S, Pruna L, Kaminsky P.
    Presse Med; 2013 Sep 21; 42(9 Pt 1):e281-4. PubMed ID: 23477718
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.